Valuation : Vext Science, Inc.

Market Cap 46.63M 40.1M 37.83M 34.47M 64.43M 4.46B 65.01M 451M 173M 2.26B 175M 171M 7.18B P/E 2026 *
-
P/E 2027 * 18.6x
Enterprise Value 66.14M 56.88M 53.67M 48.89M 91.4M 6.32B 92.23M 639M 246M 3.21B 248M 243M 10.19B EV / Sales 2026 *
1.23x
EV / Sales 2027 * 0.8x
Free-Float
40.74%
Yield 2026 *
-
Yield 2027 * -
1 day+1.92%
1 week-1.85%
Current month-3.64%
1 month+6.00%
3 months+1.92%
6 months+3.92%
Current year+3.92%
1 week 0.25
Extreme 0.25
0.28
1 month 0.25
Extreme 0.25
0.32
Current year 0.22
Extreme 0.22
0.4
1 year 0.19
Extreme 0.19
0.4
3 years 0.1
Extreme 0.1
0.42
5 years 0.1
Extreme 0.1
0.92
10 years 0.1
Extreme 0.1
2.1
Manager TitleAgeSince
Chief Executive Officer - 2020-02-17
Director of Finance/CFO - 2023-08-24
Investor Relations Contact - -
Director TitleAgeSince
Chairman 45 2015-12-10
Director/Board Member - 2020-02-13
Chairman 69 2024-08-19
Date Insider Type Main position Quantity % Market Cap. Importance
1/5/26 Sell

Director

1,334,000 0.8075%
1/5/26 Sell

Founder

20,340 2.9973%
1/5/26 Other

Director

0 0%
Change 5-day change 1-year change 3-year change Capi.($)
+1.92%-1.85%-15.87%-3.64% 46.63M
-3.20%-0.69%+14.09%+171.23% 363M
-3.27%-6.33%-35.09%-41.50% 156M
+1.53%+0.51%+15.03%+103.06% 140M
-1.04%+7.95%-32.14%-62.89% 97.54M
-1.41%-0.49%-40.46%-48.25% 64.04M
Average -0.91%-0.86%-15.74%+19.67% 144.58M
Weighted average by Cap. -1.80%+0.13%-5.44%+70.05%

Financials

2026 *2027 *
Net sales 53.8M 46.27M 43.65M 39.77M 74.34M 5.14B 75.02M 520M 200M 2.61B 202M 198M 8.29B 68.83M 59.19M 55.85M 50.88M 95.11M 6.58B 95.98M 665M 256M 3.34B 258M 253M 10.6B
Net income -900K -774K -730K -665K -1.24M -86.05M -1.25M -8.7M -3.35M -43.64M -3.38M -3.31M -139M 3.22M 2.77M 2.61M 2.38M 4.45M 308M 4.49M 31.12M 11.98M 156M 12.09M 11.83M 496M
Net Debt 19.52M 16.78M 15.84M 14.43M 26.97M 1.87B 27.21M 189M 72.59M 946M 73.29M 71.69M 3.01B 8.69M 7.47M 7.05M 6.42M 12.01M 831M 12.12M 83.97M 32.32M 421M 32.63M 31.92M 1.34B
Logo Vext Science, Inc.
Vext Science, Inc. is a cannabis operator with vertical operations in Arizona and Ohio. The Company's expertise spans from cultivation through to retail operations in its key markets. The Company owns and operates cultivation facilities, fully built-out manufacturing facilities as well as dispensaries in both Arizona and Ohio. The Company produces a range of branded offerings, including its Vapen, Revibe, Herbal Wellness Center, and Appalachian Pharm lines. The Company manufactures Vapen, one of the THC concentrates, edibles, and distillate cartridge brands in Arizona. It produces CBD products under the Vapen CBD and Hempy Endings brands, manufactured at its Vapen Kentucky facility. Through strategic licensing agreements, it manufactures the Microbar brand in Arizona. The Company extends its services to the cannabis industry by offering management, advisory, cultivation, non-cannabis products, and dispensary services through operating agreements and direct sales to various entities.
Employees
-
Date Price Change Volume
26-09-10 CA$0.2650 +1.92% 45,500
26-09-09 CA$0.2600 -1.89% 76,500
26-09-08 CA$0.2650 +1.92% 87,000
26-09-04 CA$0.2600 -3.70% 66,500
26-09-03 CA$0.2700 -1.82% 21,000
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.2600CAD
Average target price
0.9500CAD
Spread / Average Target
+265.38%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VEXT Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!